Belite Bio, Inc Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Belite Bio, Inc (BLTE) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $3.85 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-03-31
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|
| 2025-12-31 | $3.85M 20-F · filed 2026-03-31 |
| 2024-12-31 | $2.46M 20-F · filed 2026-03-31 |
| 2023-12-31 | $1.42M 20-F · filed 2026-03-31 |
| 2022-12-31 | $373.00K 20-F · filed 2025-03-17 |
| 2021-12-31 | $632.00K 20-F · filed 2024-03-12 |
| 2020-12-31 | -$254.00K 20-F · filed 2023-03-31 |